跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 143,534 条关于
“CD19-directed CAR T-cell therapy”
全部
143,534
临床试验
109,355
药物
9,199
机构
658
资讯
24,322
3个月前
Female Sex Linked to Superior Outcomes in CD19-Directed CAR T-Cell Therapy for Large B-Cell Lymphoma
11天前
PeproMene Bio's BAFF-R CAR T-Cell Therapy Shows 80% Complete Response Rate in Relapsed/Refractory B-Cell Lymphomas
10天前
Lancet Publishes Phase 1 Data for PeproMene's BAFF-R CAR T: 80% Complete Response, Grade 1-Only Toxicity
3个月前
PeproMene Bio's BAFF-R CAR-T Therapy Shows 78% Complete Response Rate in B-Cell Lymphoma Patients After CD19 CAR-T Failure
去年
CAR-T Therapy Shows Promise in Lenalidomide-Refractory Multiple Myeloma
去年
India's Indigenous CAR T-Cell Therapy Shows Promise in Treating Blood Cancers
3个月前
Dual-Target CD19/BCMA CAR T-Cell Therapy Demonstrates Profound Remission in Refractory Systemic Sclerosis
去年
Breyanzi Receives Positive CHMP Opinion for Follicular Lymphoma Treatment in EU
9个月前
ALETA-001 Shows Promise in Phase I/II Trial for Relapsed B-Cell Malignancies After CAR-T Therapy
9个月前
FDA Approves Breyanzi CAR-T Cell Therapy for Relapsed/Refractory Marginal Zone Lymphoma
第 1 页，共 2433 页
上一页
下一页
